Skip to content
PeptideRank
Henry Meds logo

Provider review

Henry Meds cost: From $179/mo tirzepatide

Its own pages don't agree on which pharmacy category applies.

The tirzepatide page hedges between 503A and 503B; its Terms of Service state 503A alone — and neither names an actual pharmacy.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What Henry Meds discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Disclosed

The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit Henry Meds

Pharmacy

Not categorized

Labs

Not stated on site

States

Not published

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Not confirmed

Shipping

Not confirmed

Lab work

Not disclosed

Coaching

Not disclosed

See plans at Henry Meds

Prices read from Henry Meds's own site · August 2026

What they advertise

Henry's own FAQ and treatment pages state plainly, "The price of GLP-1 medication varies by treatment plan and dosing, but starts at $179/month" — one monthly payment advertised to include "provider visit, medication and supplies, and ongoing care."

What you actually pay

There is no confirmed tirzepatide-specific number above that $179 floor: Henry's own pages state the $179 figure for its GLP-1 catalog broadly (semaglutide, tirzepatide tablets, and more) rather than breaking tirzepatide out on its own, and it publishes no dose-tier price list at all.

Money you will meet later

  • Optional multi-month plans exist and may lower the effective monthly rate, but canceling one early for a non-medical reason means you "may be required to pay out the rest of your balance," per Henry's own FAQ.

The bottom line

Henry Meds sells compounded oral tirzepatide tablets with one advertised monthly price, "starts at $179/month," covering the provider visit, medication, and supplies together. What we could not reconcile: its own tirzepatide page says compounding happens in "a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility," while its own Terms of Service state, separately, that medications "are prepared in accordance with Section 503A" — two pages on the same site giving two different answers, and neither naming an actual pharmacy. The default plan is month-to-month with no long-term contract, but an optional multi-month plan carries a real early-cancellation cost its FAQ discloses only in the fine print.

Henry Meds appears on our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • A single advertised monthly figure that bundles the provider visit, medication, and supplies together is simpler for you than itemized pricing.
  • You want the option to cancel a month-to-month plan any time, with no long-term contract by default.
  • You want a provider that states its FDA-approval status plainly, rather than leaving it implied.

Look elsewhere if

  • You want a provider whose own site consistently names one regulatory category for its pharmacy — Henry's tirzepatide page and its Terms of Service state two different things.
  • Seeing a tirzepatide-specific dollar figure before signing up matters — the published $179 floor covers Henry's whole GLP-1 catalog, not tirzepatide alone.
  • You're considering a multi-month plan for the savings — read the cancellation terms first, since an early exit for a non-medical reason can mean paying out the remaining balance.

What Henry Meds offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

Henry Meds does not name the pharmacy that fills your prescription.

What its own site says

Not named. Henry's own tirzepatide-tablets and GLP-1 pages both describe medication as compounded "in a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility" — hedging between the two rather than naming one — while its separate Terms of Service state medications "are prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act." The two pages do not agree, and neither names an actual pharmacy.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not published

Not published. Henry's own FAQ and Terms of Service both say only that a customer must "Live or have an address in one of the states we support," with no list given; the Terms of Service adds that availability "may change...at any time." California is flagged only for slower fulfillment, not exclusion.

The honest cons

The part they would rather you skipped

Henry Meds' own pages contradict each other on the one fact this site is built to check: its tirzepatide page hedges between "a 503(A) Compounding Pharmacy or 503(B) Outsourcing Facility," while its Terms of Service state "Section 503A" alone — and if you sign up for an optional multi-month plan and need to stop for a non-medical reason, its own FAQ says you "may be required to pay out the rest of your balance."

  • Its own pages disagree on which regulatory category applies to its compounding pharmacy, and neither names an actual pharmacy
  • "Starts at $179/month" is stated for its whole GLP-1 catalog, not confirmed as tirzepatide's own number, and no dose-tier breakdown is published
  • An optional multi-month plan carries an early-cancellation balance-payout risk that its default month-to-month plan does not — read the FAQ before choosing a plan length

None of this is unique to Henry Meds — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.

Ready to get started?

Prices and plans in this category change often — check Henry Meds's current pricing before you decide. Ours was read from their own site in August 2026.

See Henry Meds pricing

Facts on this page reflect Henry Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Henry Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.

Henry Meds

2 compounds, From $179/mo

Visit